Fabtech Technologies: Infusing innovation and simplifying technology for Pharmaceutical, Biotechnology and Healthcare segment
With a pool of scientific talent, R&D capabilities, and a thriving IT sector, India’s Pharmaceutical, Healthcare, and Biotechnology industry has positioned itself positively without a doubt while playing a key role in charging up the growth of Indian economy. With advancement in these fields, the shift is now focused on nurturing innovation to cater a new era of transformation. Inspired by this Mr. Aasif Khan, a global entrepreneur and a creative business genius brewed up Fabtech Technologies with a vision to deliver specialized solutions for the Pharmaceutical, Biotechnology and Healthcare industries, since then there has been no turning back. Fabtech Technologies is a global engineering innovator that over the last 17 years has built up a stellar reputation with its prowess. With over 700 specialized manufacturing installations in 42 countries, Fabtech is a powerhouse of life engineering. With a workforce of 650 dedicated designers and engineers, focused on driving innovation for the company and its customers, Fabtech is definitely making its mark for making medicines affordable globally and reduce spurious drugs by building pharmaceutical capability for our customers as well as the economies in which they operate.
Carving out as a differentiator
Fabtech’s many successful projects have been size, geography, complexity agnostic, and often delivered amidst challenging external circumstances that have thwarted others. Over the years the team DNA has become rooted in the delivery of the impossible. Since its inception, Fabtech Technologies has been catering its prowess to Pharmaceutical Industry to help them establish the world class manufacturing facility to, in turn, be able to manufacture cost-effective quality medicines. No matter where the clients are, they have access to Fabtech’s glocal engineering taskforce stationed in Asia, Europe, Africa, Australia and the Americas. Fabtech’s is uniquely positioned as a capability building catalyst for organizations in the Pharmaceutical, Biotechnology and Healthcare industries. The model is defensible and disruptive and its proven process rooted in the principles of discontinuous innovation. With all of its expertise and ability, Fabtech enjoys a relative monopoly in the spectrum. Following are the ways that make the firm stand out and apart from the clutter:
- Fabtech’s innovation culture
- Veterans of glocalization; with a global reach with over 42 countries on over 700 projects over a span of 17 years
- Emphasized on managing every stage of the project management cycle in-house – from consulting to design to manufacturing to support with a commitment to delivering beyond customer expectations on every project – whether costs, flexibility or operability.
- Specialized manufacturing facilities and certification from global agencies – ASTM INTERNATIONAL, BODYCOTE & BRI – POLAND
- Customer ecosystem; strong reference base
Over the years Fabtech’s business model has evolved from design and manufacture of cleanroom solutions for the pharmaceutical and biotech industries to end-to-end capability building for organizations in the Pharmaceutical, Biotechnology and Healthcare industries. The model is defensible and disruptive and organization’s proven process is rooted in the principles of discontinuous innovation. Fabtech’s expansion has been remarkable with a CAGR of 32%, with 72% repeat clients in India as well as internationally while carrying out operations over 42+ geographies worldwide.
Fabtech at a Glance
Strategy: To invest in handpicked companies having innovative streak and come closer to our customers to fulfill their needs
Goals: To be an innovative, global, integrated process engineering enabler/integrator to the Pharma biotech and health care sector
To deploy right domain experts and advanced technologies to be a perfect partner
To invest in infrastructure and resources to manufacture chosen critical equipment
To groom our team and add value to our stakeholder’s interests and our client’s investments in our journey
Catering the prowess with its solutions
Fabtech’s capability building portfolio for its customers includes
- Needs analysis
- Business Model generation
- Relationship facilitation (between customers, between customers and new markets, between customers and governments)
- Turnkey design, build and manufacturing of the speciality pharmaceutical, biotech or healthcare manufacturing facility
Fabtech’s state of the art manufacturing facilities are spread over 200,000 sq. feet of floor space in Umergaon and Vasai and cater to all specialty manufacturing needs across the spectrum including modular panels and internal Infrastructure, cleanroom and air sterilization and micro-contamination control equipment, containment solutions, process equipment for oral solids and Liquid injectables, primary packaging solutions – capsule fillers and injectable lines and water treatment plants. With the deep understanding of global pharmaceutical and product mapping patterns and formulation development in India, Fabtech’s proven process and its ability to life-engineer a combination of systems and solutions for each specialized manufacturing facility has delivered desired results for its clientele. Also, the firm has also deployed some strategic initiatives for:
- Export initiatives, by conducting road shows in the market of interest, tie-ups with Pharma-medical agencies and participation in all the key regional tradeshows.
- Expansion plans, Fabtech is looking at capacity additions as well as an acquisition in the pharma tech space in Europe over the next 12 months
- Technical/marketing collaborations- Fabtech’s international advisory panel includes Dr. Douglas Thorogood, U.K, Dr. Jeff Yuen (Ex-US FDA), Steve Slater – Traque Asia and Julian Wilkins, Founder PharmaConsult US, Inc
While entering a new market, Fabtech ties up with the local regulatory authorities and funding agencies to enjoy first-mover advantages. The organization also has local offices and its own sales network in almost every market, making it the first Indian company to do so. Additionally, the firm has also invested heavily in inbound and digital marketing to reach a wider audience base.
Expansion Binge & Future Ahead
Fabtech is expanding globally with an aim to place itself further at the pinnacle of the segment. The company has bagged numerous accolades and various recognitions, including being rated as one of the prime Pharma and biotechnical integrators of India. The organization has been recognized worldwide for its technology breakthroughs and innovations. The proud list of achievements enlists awards for excellent project management, outstanding engineering expertise and for the best environment, health and safety (EHS) practices. Many notable entities including Mylan, Lupin, Cipla, Asia Pharmaceutical Industry, Johnson & Johnson, Sandoz Wockhardt, Merck, Biocon, Ranbaxy, Celon Labs, Biopil, Emcure, Incepta, Novartis, Iorten, Zydus Cadila, Glenmark, Unichem and many more have been availing the expertise of Fabtech. Presently Fabtech’s immediate focus is on building pharmaceutical capability in the emerging markets. The organization is creating a wider footprint in 27 markets to cater its expertise for serving presence and local and technical backup. The firm is also expanding its technical capability and developing local manufacturing presence in GCC and Africa.
The mind behind Fabtech Technologies
CMD & Founder member
Passionate about ‘Innovation’, Aasif heads Fabtech Technologies. Possessing a seasoned experience of almost 3 decades in the arena of engineering and International project, Aasif has set international footprints with his growing business, generating revenue for the group and ROI for the investors. A mechanical engineer by qualification, Aasif has been a visionary and a charismatic leader to Fabtech’s team of over 500 professionals which includes Biotechnologists, Pharmacists, Process Engineers, RND Professionals, Planners, and Engineers. His excellent man-management skills and ability to build highly efficient, functional and motivated teams have made him an admired persona within the company and across the industry. At heart, he has always been a creative business genius, with an inherent ability to spot opportunities in different business segments and in geographies around the world.